Panels designed to identify acute cellular rejection, antibody-mediated rejection without ...

Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument (also known as VEL-101), a novel investigational ...

Transplantation of organs or tissues between genetically nonidentical individuals of the same species (and different species) is plagued by rejection and its associated problems. "Foreignness" is ...

About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung ...

SAN DIEGO -- Kidney transplant patients who shifted into newly recognized microvascular inflammation categories under revised definitions had an intermediate risk of poor allograft outcomes, a large ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

If an organ in your body (such as the heart, kidneys, or liver) is not working well enough because of an illness or injury, you may need an organ transplant. An organ transplant involves surgically ...

When a transplanted organ arrives, it’s like a controlled burn that risks becoming a wildfire. The body’s innate immune system senses damage signals, like heat shock proteins (HSP70), and sounds the ...

Despite the known risk factors for CR, it is not possible to predict which patients will develop CR and at what time point after transplant. Given the significant morbidity and mortality associated ...

Investigational methods to predict transplant rejection are employing donor-derived cell-free DNA or transplant recipients’ immune cells. Several teams of investigators are developing noninvasive ...

After lung transplantation, infection with Pseudomonas aeruginosa independently predicted antibody-mediated rejection (AMR), researchers found. Through a series of mouse-model studies, the researchers ...